Market Research

Addison's Disease Treatment Market by Drug Class (Glucocorticoid, Mineralocorticoid), Diagnosis (Imaging Testing, Laboratory Testing), Treatments, Distribution Channel, Route of Administration - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 195 Pages 360iResearch January, 2024 IRE18417907
Best Price Guarantee
Price from $4,749
Length 195 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18417907

Addison's Disease Treatment Market by Drug Class (Glucocorticoid, Mineralocorticoid), Diagnosis (Imaging Testing, Laboratory Testing), Treatments, Distribution Channel, Route of Administration - Global Forecast 2024-2030


The Addison's Disease Treatment Market size was estimated at USD 1.41 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 10.72% to reach USD 2.88 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Addison's Disease Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Addison's Disease Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Addison's Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Actiza Pharmaceutical Private Limited, Akorn Operating Company LLC, Amgen Inc., Amneal Pharmaceuticals, Inc., Bay Biosciences LLC, Bayer AG, Bio-Techne Corporation, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, BTL Biotechno Labs Pvt Ltd., Cardinal Health, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, LUMITOS AG, Lupin Limited, Merck KGaA, Neurocrine Biosciences, Inc., Novartis AG, Pfizer Inc., Recipharm AB, Sandoz International GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Addison's Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class

Glucocorticoid

Dexamethasone
  • Hydrocortisone
  • Prednisone
  • Mineralocorticoid

    Fludrocortisone
  • Diagnosis

    Imaging Testing
  • Laboratory Testing
  • Treatments

    Corticosteroid Injections
  • Naturopathic Solutions
  • Oral Corticosteroids
  • Distribution Channel

    E-Commerce
  • Hospital Pharmacy
  • Retail Pharmacy
  • Route of Administration

    Oral
  • Parental
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Addison's Disease Treatment Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Addison's Disease Treatment Market?
    3. What are the technology trends and regulatory frameworks in the Addison's Disease Treatment Market?
    4. What is the market share of the leading vendors in the Addison's Disease Treatment Market?
    5. Which modes and strategic moves are suitable for entering the Addison's Disease Treatment Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Addison's Disease Treatment Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rising incidences of Addison's disease globally
    5.1.1.2. Growing awareness regarding adrenal insufficiency
    5.1.1.3. Inception of robust healthcare infrastructure and favorable reimbursement policies
    5.1.2. Restraints
    5.1.2.1. High costs associated with the Addison treatment medications
    5.1.3. Opportunities
    5.1.3.1. Growing demand for new generation technologically integrated advanced therapeutic drugs
    5.1.3.2. Increasing R&D activities and rising focus of the companies in developing treatments for Addison's disease
    5.1.4. Challenges
    5.1.4.1. Lack of awareness among people regarding Addison's disease
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Addison's Disease Treatment Market, by Drug Class
    6.1. Introduction
    6.2. Glucocorticoid
    6.3.1. Dexamethasone
    6.3.2. Hydrocortisone
    6.3.3. Prednisone
    6.3. Mineralocorticoid
    6.4.1. Fludrocortisone
    7. Addison's Disease Treatment Market, by Diagnosis
    7.1. Introduction
    7.2. Imaging Testing
    7.3. Laboratory Testing
    8. Addison's Disease Treatment Market, by Treatments
    8.1. Introduction
    8.2. Corticosteroid Injections
    8.3. Naturopathic Solutions
    8.4. Oral Corticosteroids
    9. Addison's Disease Treatment Market, by Distribution Channel
    9.1. Introduction
    9.2. E-Commerce
    9.3. Hospital Pharmacy
    9.4. Retail Pharmacy
    10. Addison's Disease Treatment Market, by Route of Administration
    10.1. Introduction
    10.2. Oral
    10.3. Parental
    11. Americas Addison's Disease Treatment Market
    11.1. Introduction
    11.2. Argentina
    11.3. Brazil
    11.4. Canada
    11.5. Mexico
    11.6. United States
    12. Asia-Pacific Addison's Disease Treatment Market
    12.1. Introduction
    12.2. Australia
    12.3. China
    12.4. India
    12.5. Indonesia
    12.6. Japan
    12.7. Malaysia
    12.8. Philippines
    12.9. Singapore
    12.10. South Korea
    12.11. Taiwan
    12.12. Thailand
    12.13. Vietnam
    13. Europe, Middle East & Africa Addison's Disease Treatment Market
    13.1. Introduction
    13.2. Denmark
    13.3. Egypt
    13.4. Finland
    13.5. France
    13.6. Germany
    13.7. Israel
    13.8. Italy
    13.9. Netherlands
    13.10. Nigeria
    13.11. Norway
    13.12. Poland
    13.13. Qatar
    13.14. Russia
    13.15. Saudi Arabia
    13.16. South Africa
    13.17. Spain
    13.18. Sweden
    13.19. Switzerland
    13.20. Turkey
    13.21. United Arab Emirates
    13.22. United Kingdom
    14. Competitive Landscape
    14.1. FPNV Positioning Matrix
    14.2. Market Share Analysis, By Key Player
    14.3. Competitive Scenario Analysis, By Key Player
    15. Competitive Portfolio
    15.1. Key Company Profiles
    15.1.1. Abbott Laboratories
    15.1.2. Actiza Pharmaceutical Private Limited
    15.1.3. Akorn Operating Company LLC
    15.1.4. Amgen Inc.
    15.1.5. Amneal Pharmaceuticals, Inc.
    15.1.6. Bay Biosciences LLC
    15.1.7. Bayer AG
    15.1.8. Bio-Techne Corporation
    15.1.9. Biogen Inc.
    15.1.10. Boehringer Ingelheim International GmbH
    15.1.11. Bristol-Myers Squibb Company
    15.1.12. BTL Biotechno Labs Pvt Ltd.
    15.1.13. Cardinal Health, Inc.
    15.1.14. Eli Lilly and Company
    15.1.15. GlaxoSmithKline PLC
    15.1.16. Hikma Pharmaceuticals PLC
    15.1.17. LUMITOS AG
    15.1.18. Lupin Limited
    15.1.19. Merck KGaA
    15.1.20. Neurocrine Biosciences, Inc.
    15.1.21. Novartis AG
    15.1.22. Pfizer Inc.
    15.1.23. Recipharm AB
    15.1.24. Sandoz International GmbH
    15.1.25. Takeda Pharmaceutical Company Limited
    15.2. Key Product Portfolio
    16. Appendix
    16.1. Discussion Guide
    16.2. License & Pricing
    FIGURE 1. ADDISON'S DISEASE TREATMENT MARKET RESEARCH PROCESS
    FIGURE 2. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
    FIGURE 3. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ADDISON'S DISEASE TREATMENT MARKET DYNAMICS
    FIGURE 7. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
    FIGURE 8. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
    FIGURE 10. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2030 (%)
    FIGURE 12. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 14. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
    FIGURE 16. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 20. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 25. ADDISON'S DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 26. ADDISON'S DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings